BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) earnings per share and revenue

0QNA earnings per share for the last semiannual are 1.61 CHF whereas the estimation was 1.17 CHF which accounts for 37.61% surprise. Company revenue for the same period amounts to 76.30 M CHF despite the estimated figure of 106.10 M CHF. Estimated earnings per share for the next semiannual are 2.48 CHF, and revenue is expected to reach 123.50 M CHF. Also watch annual changes over time to get a bigger picture of 0QNA earnings per share and revenue dynamics.